2 hrs ago
Krsnaa Diagnostics Shares Jump After Entering PET-CT Segment
Krsnaa Diagnostics is a company that provides medical testing services.
It is starting to offer PET-CT scans, which are specialised health tests.
The project is connected to the Government of Punjab.
The company will run the project with the government for 15 years.
It will build, finance, operate, maintain, and eventually transfer the facilities.
The company expects the project to create a new source of revenue.
However, its earnings will depend on how many people use the service and the fees they pay.
Investors reacted positively, and the company’s share price rose sharply.
Krsnaa Diagnostics shares rose as much as 11.4% to ₹597.95 on BSE on Thursday, 17 September.
The company entered the PET-CT diagnostic services segment through a Punjab government healthcare project.
The project will operate under a 15-year Public Private Partnership concession using the DBFOT model.
Revenue will depend on the number of PET-CT scans and applicable user charges, so total consideration cannot be determined upfront.
Despite the surge, the stock remains 33% below its 52-week high of ₹891.80 reached in September 2025.
- Who
- Krsnaa Diagnostics, the Government of Punjab and Punjab Health Systems Corporation are involved.
- What
- Krsnaa Diagnostics entered the PET-CT diagnostic services segment through a government healthcare concession.
- Where
- The project will use established government hospital locations in Punjab.
- When
- The share-price move occurred on Thursday, 17 September; the Letter of Award was dated 14 August 2026.
- Why
- The company cited growing demand for PET-CT services and an opportunity to expand its government healthcare partnerships and revenue sources.
Key facts
- Intraday share-price gain
- 11.4%
- Intraday high
- ₹597.95 per share on BSE
- Concession period
- 15 years
- Project model
- Public Private Partnership under the Design, Build, Finance, Operate, Maintain and Transfer format
- Revenue model
- Cash-based, depending on PET-CT scans and applicable user charges
- 52-week high
- ₹891.80, reached in September 2025
- 52-week low
- ₹502.20, reached in March 2026
Quotes
Krsnaa Diagnostics
The company announcing its decision to enter the PET-CT segment.
“The Company has historically taken a measured approach towards the PET-CT segment and had not pursued opportunities in this segment earlier. However, considering the growing demand for PET-CT diagnostic services and the opportunity to leverage its established capabilities in government healthcare partnerships, the Company has now decided to enter this segment through a PPP opportunity.”
livemint.com
“The combination of a long-term concession framework, cash-based revenue model and access to established Government Hospital locations provides a strong foundation for the Company's measured entry into the PET-CT segment and further diversifies its revenue opportunities.”
livemint.com
Sources
Related news
Park Medi World Rises Fifth Session on Prayagraj Hospital Mandate
Integrated Laboratory Opens at Guntakal Hospital to Expand Diagnostics
Krystal Integrated Services Shares Rise on ₹134 Crore Order
Lord's Mark Industries Unveils ₹1,550 Crore Healthcare Expansion Plan
Lord’s Mark Plans Healthcare Expansion, Revenue Growth and Energy Demerger
Molbio Diagnostics Shares Hit Upper Circuit After Strong IPO Rally
Punjab Free Power Strains Finances and Raises Blackout Fears
AAP Faces Law, Governance Challenges Ahead Of Punjab Polls
Indian Farmers Receive First Carbon Credit Payments for Sustainable Practices
Border Security, Punjab Violence, Hospital Mystery and Flood Response
